The DNA, RNA, and protein of apo C-II have been analyzed in a patient with apo C-II deficiency (apo C-IIHsbm). Markedly reduced levels of plasma and intrahepatic C-II apolipoprotein were demonstrated by immunoblotting and immunohistochemical analysis. Northern, slot blot, and in situ hybridization studies revealed low levels of a normal-sized apo C-II mRNA. No major rearrangement of the apo C-II gene was detected by Southern blotting. Sequence analysis of apo C-IT genomic clones revealed a G-to-C substitution within the donor splice site of intron II. This base substitution resulted in the formation of a new Dde I and loss of a Hph I restriction enzyme cleavage site. Amplification of the mutant sequence by the polymerase chain reaction and digestion with Dde I and Hph I restriction enzymes established that the patient was homozygous for the G-to-C mutation. This is the initial report of the DNA sequence of an abnormal apo C-II gene from a patient with deficiency of apo C-IL. We propose that this donor splice site mutation is the primary genetic defect that leads to defective splicing and ultimately to an apo C-II deficiency in this kindred.
Introduction
Apo C-IT plays a central role in triglyceride metabolism as a cofactor for the enzyme lipoprotein lipase. The importance of apo C-II as an activator ofthis enzyme has been established by the absence of lipoprotein lipase activity in patients with an apo C-IT deficiency. This syndrome, which is inherited as an autosomal recessive trait, has been described in several kindreds (1) (2) (3) (4) (5) (6) (7) (8) . Patients homozygous for apo C-II deficiency have marked derangements in triglyceride metabolism, including an elevation of plasma triglycerides, chylomicrons, and VLDL, as well as eruptive xanthomas and an increased incidence of pancreatitis. The diagnosis of apo C-II deficiency is established by finding a virtual absence ofapo C-II in plasma associated with reduced postheparin lipoprotein lipase activity that is corrected by the addition ofnormal apo C-IT-containing plasma. Patients with near normal levels of a nonfunctional apo C-Il variant are also designated as patients with apo C-II deficiency. Transient normalization of triglyceride and lipoprotein abnormalities present in the plasma of apo C-II-deficient patients can be achieved by infusion of normal plasma (1, 3, 7) , purified apo C-II (5), or synthetic apo C-1I fragments (7) .
Of the various kindreds described with an apo C-II deficiency, two have been identified with an abnormal plasma apo C-II. Apo C-IIT0~nt, a nonfunctional C-II apolipoprotein, has a different amino acid sequence at amino acids 64-74, as well as loss of amino acids 75-79 when compared with normal apo C-II (8) . Apo C-IIst. Michael has an altered sequence starting with a proline substituted for a glutamine at position 70 and the abnormal apo C-II sequence is extended 17 residues past the normal carboxyl-terminal amino acid (9) . These abnormalities are most consistent with a base deletion for apo C-IITOrontO and a base insertion for apo C-IIs, Michael, resulting in a subsequent shift of the translation reading name; however, the precise DNA defect in these two kindreds has not been determined.
Studies of the apo C-II gene in apo C-II-deficient patients at the DNA level have been limited to Southern blot hybridization analyses that have not, thus far, revealed any major rearrangements of the apo C-II gene (10, 1 1) .
In this study, we investigate the molecular defect at the gene level in a kindred with apo C-II deficiency, apo C-IIHzbUg. A donor splice site mutation in the second intron of the apo C-IIHaburg gene was identified by sequence analysis of the proband's DNA. We propose that this mutation is the basis for the deficiency of apo C-TI in this kindred.
Methods
Clinical data. The proband is a 30-yr-old female of Turkish descent followed in the Medizinische Kern- Electrophoretic analysis of the plasma apo C-II protein. Twodimensional gel electrophoresis of plasma, consisting of isoelectric focusing followed by SDS gel electrophoresis, was performed as described previously (12) . The gels were stained by the silver stain method (13, 14) . The (21) . In situ RNA hybridization was performed as previously described (21) except that the samples were counterstained with Mayer's hematoylin and eosin (American Histolabs, Bethesda, MD).
Cloning and screening ofgenomic libraries and isolation ofapo C-II clones. DNA from the apo C-Il-deficient subject was partially digested with the restriction enzyme Mbo I and the DNA ligated to EMBL3 vector DNA. Escherichia coli P2392 was then infected with the EMBL3 recombinant phage. Screening of the library with a radiolabeled apo C-II cDNA probe and large scale preparation of phage DNA were as previously described (22 Restriction enzymes. All restriction enzyme used were from New England Biolabs (Beverly, MA) and the digestion conditions were as recommended by the manufacturer.
Results Fig. 1 illustrates the pattern of apolipoproteins present in the plasma of normal (Fig. 1 A) and the apo C-II-deficient (Fig. 1  B) subjects. Absence of the normal apo C-II isoform in the plasma of the proband, based on silver staining, is illustrated in Fig. 1 B. The more sensitive method of immunoblotting demonstrates low levels of an apo C-II protein that exhibits normal electrophoretic mobility on two-dimensional gel analysis of the patient's plasma (Fig. 1 D) .
Immunohistochemical analysis of liver incubated with an anti-apo C-II MAb revealed low but detectable intrahepatic levels of apo C-II in the patient (Fig. 2 C) when compared with normal levels (Fig. 2 B) based on the intensity of the brown staining. Normal liver, when incubated with either the preimmune (data not shown) or irrelevant MAb (Fig. 2 A) , showed no cytoplasmic staining. Specificity of the procedure is also demonstrated by the lack of staining within connective tissue, which is not expected to contain the C-II apolipoprotein (Fig. 2 B) .
Northern blot analysis of 8 Aig of total RNA isolated from normal and patient's liver revealed the apo C-II mRNA of the patient to be of normal size but decreased in quantity when compared with the apo C-TI mRNA from normal patients (Fig.  3 D) . Ethidium bromide staining of the gel confirmed that equivalent amounts of nucleic acid had been electrophoresed in all lanes (Fig. 3 A) . Stripping and rehybridization of the blot with nick-translated , actin and apo A-I cDNA probes followed by autoradiography revealed that nearly equal levels of both of these mRNAs were present in hepatocytes from both the apo C-Il-deficient patient and normal subjects (Fig. 3, B and C).
Further quantitation of the level of apo C-Il mRNA in the liver of the apo C-Il-deficient patient was performed by slot blot and in situ RNA hybridization. Low but detectable levels ofapo C-Il message visualized as black grains by in situ hybridization are evident in the liver of the apo C-II-deficient patient 1 . Abbreviations used in this paper: PCR, polymerase chain reaction. ( Fig. 4 C) after hybridization with the apo C-II antisense RNA when compared with normal liver (Fig. 4 B) . Specificity of the procedure was demonstrated by both the absence of grains within connective tissue (Fig. 4 B) the lack of hybridization of the apo C-II sense RNA with normal liver (Fig. 4 A) Sequence analysis of two apo C-II genomic clones isolated from the DNA library of the apo C-Il-deficient patient revealed a G-to-C substitution at the highly conserved first nucleotide position in the 5' splice site of intron II (Fig. 5 A) . Consensus donor splice site and normal apo C-II sequences are also illustrated in Fig. 5 A. Autoradiographs of sequence gels from normal and apo C-II-deficient subjects illustrating the G-to-C substitution are shown in Fig. 5 , B and C.
Computer analysis (Fristensky-Cornell DNA Sequencing Analysis Program) of the patient's apo C-Il gene sequence containing the G-to-C substitution revealed a new Dde I site at position 2,715 and the loss of a normal Hph I restriction site at position 2,725 as compared with the normal apo C-Il gene (22) .
Amplification of the apo C-Il gene from normal and apo C-II-deficient subjects was performed using the PCR and synthetic oligonucleotides illustrated in Fig. 6 A. The amplified product was 457 bp long. Digestion of DNA amplified from a normal subject with Dde I generated two fragments of 393 and 64 bp in size, but digestion of the patient's amplified DNA with the same enzyme resulted in the formation of three fragments of 69, 324, and 64 bp in size. Digestion of DNA amplified from a normal subject with Hph I generated four fragments of 80, 202, 28, and 147 bp in size, whereas digestion of the patient's amplified DNA with the same enzyme resulted in the formation of three fragments of 282, 28, and 147 bp in length. Analysis of the restriction enzyme fragments of the amplified DNA from the patient and normal subjects by agarose gel electrophoresis is illustrated in Fig. 6 B. Absence of normal-sized restriction fragments in the DNA ofthe apo C-Il deficient patient indicates that the proband is a true homozygote with both apo C-Il alleles having the same mutation.
Southern blot hybridization analysis of normal and patient DNA digested with Dde I and Hph I confirmed this finding (data not shown).
Discussion
In this study we have analyzed the DNA, RNA, and protein from the proband with apo C-Il deficiency from the Hamburg kindred. RIA mRNA and protein in the liver and low levels of the C-II apolipoprotein in plasma. These data are most consistent with a small DNA mutation that interferes with the normal transcription and processing of the apo C-II mRNA and/or destabilizes the apo C-II mRNA in the liver.
Sequence analysis of the apo C-IIHambu.g gene revealed a single-base substitution (G to C) at the first base of intron IT. This study represents the first elucidation ofa molecular defect at the DNA level in a patient with a deficiency ofapo C-IT. The G-to-C mutation alters the highly conserved dinucleotide invariant at the 5' splice site in structural genes and would be anticipated to result in defective processing of the apo C-IlHamburg mRNA (25, 26) . We thus postulate that this donor splice site mutation is the primary genetic abnormality that results in a deficiency of apo C-II in this kindred. Because this rearrangement involves a single-point mutation, no major abnormality of the apo C-II gene is detected by Southern blot analysis.
Abnormal splicing ofthe # globin RNA has been described in patients with fl3-thalassemia that have G for A or G for T mutations of the GT dinucleotide (27, 28) . In these patients, splicing at the altered junction is completely abolished and alternate cryptic donor-like sequences located elsewhere in the RNA precursor are used in splicing. The resulting alternatively spliced mRNAs are frequently unstable and rapidly degraded. In a recent study, a G-to-C point mutation, identical to that present in our patient's gene, was introduced into the large 1B globin intron (29) . In vitro expression of the altered gene revealed that a small quantity of splicing occurred one base upstream from the normal splice site, as well as in other cryptic splice sites with this mutation. In the apo CGIIHamburg gene, however, it is very likely that despite the mutation in the critical GT dinucleotide, a small amount of correctly spliced message is made resulting in the low but detectable levels of normal-sized apo C-II message visualized by our Northern, slot blot, and in situ hybridization studies. Translation of this normally spliced apo C-II mRNA and secretion of the synthesized protein would result in the low plasma levels ofthe normal apo C-II isoform identified by our immunoblot studies.
Restriction enzyme digestion with the restriction enzymes Dde I and Hph I of the proband's genomic DNA, and DNA amplified by the PCR, confirm the presence of the G-to-C substitution within intron II identified by our sequencing studies. A new Dde I site is created and an Hph I site destroyed by the G-to-C mutation resulting in the formation of unique restriction fragments that were identified in our gel analysis studies. The absence of normal restriction fragment bands confirms that the proband is a true homozygote for the G-to-C mutation, with both apo C-II alleles having the same genetic defect. These results are consistent with the family history of consanguinity.
Thus 
